Jeffrey S. Parkin

Array ( [id] => 5106974 [patent_doc_number] => 20070065852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'HIV recombinant vaccine' [patent_app_type] => utility [patent_app_number] => 11/512315 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11768 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065852.pdf [firstpage_image] =>[orig_patent_app_number] => 11512315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773024 [patent_doc_number] => 08119140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins' [patent_app_type] => utility [patent_app_number] => 11/990222 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 28 [patent_no_of_words] => 9571 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119140.pdf [firstpage_image] =>[orig_patent_app_number] => 11990222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733477 [patent_doc_number] => 20060258594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/491755 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258594.pdf [firstpage_image] =>[orig_patent_app_number] => 11491755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204960 [patent_doc_number] => 20070026441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Methods for reducing viral load in HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 11/491330 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31709 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026441.pdf [firstpage_image] =>[orig_patent_app_number] => 11491330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187014 [patent_doc_number] => 20110124842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Peptide that binds to a broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex, uses thereof, compositions therefrom' [patent_app_type] => utility [patent_app_number] => 11/489162 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 101275 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124842.pdf [firstpage_image] =>[orig_patent_app_number] => 11489162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839868 [patent_doc_number] => 20080280354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/486535 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7810 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280354.pdf [firstpage_image] =>[orig_patent_app_number] => 11486535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921452 [patent_doc_number] => 20060240042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'IMMUNOGENICITY USING A COMBINATION OF DNA AND VACCINIA VIRUS VECTOR VACCINES' [patent_app_type] => utility [patent_app_number] => 11/428815 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240042.pdf [firstpage_image] =>[orig_patent_app_number] => 11428815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242126 [patent_doc_number] => 20070020619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its applications' [patent_app_type] => utility [patent_app_number] => 11/480014 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9386 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020619.pdf [firstpage_image] =>[orig_patent_app_number] => 11480014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070177 [patent_doc_number] => 20110045027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Adjuvant' [patent_app_type] => utility [patent_app_number] => 11/917961 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 32108 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045027.pdf [firstpage_image] =>[orig_patent_app_number] => 11917961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202025 [patent_doc_number] => 07632510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence' [patent_app_type] => utility [patent_app_number] => 11/424138 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21425 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632510.pdf [firstpage_image] =>[orig_patent_app_number] => 11424138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318468 [patent_doc_number] => 07521177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence' [patent_app_type] => utility [patent_app_number] => 11/424127 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521177.pdf [firstpage_image] =>[orig_patent_app_number] => 11424127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167909 [patent_doc_number] => 20110162093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'METHODS FOR PRODUCING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/922278 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16667 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20110162093.pdf [firstpage_image] =>[orig_patent_app_number] => 11922278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850607 [patent_doc_number] => 20060233798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Methods for inhibiting HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/451707 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26474 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233798.pdf [firstpage_image] =>[orig_patent_app_number] => 11451707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040252 [patent_doc_number] => 20070092534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses' [patent_app_type] => utility [patent_app_number] => 11/446050 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 52953 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092534.pdf [firstpage_image] =>[orig_patent_app_number] => 11446050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299571 [patent_doc_number] => 07537769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin' [patent_app_type] => utility [patent_app_number] => 11/445455 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 1 [patent_no_of_words] => 14639 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537769.pdf [firstpage_image] =>[orig_patent_app_number] => 11445455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834597 [patent_doc_number] => 20060246427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Method for determining the mechanism of HIV RT inhibitors' [patent_app_type] => utility [patent_app_number] => 11/443985 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10139 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246427.pdf [firstpage_image] =>[orig_patent_app_number] => 11443985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950118 [patent_doc_number] => 20080306244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Renta: an HIV immunogen and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/436958 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 27383 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306244.pdf [firstpage_image] =>[orig_patent_app_number] => 11436958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277997 [patent_doc_number] => 20090130129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use' [patent_app_type] => utility [patent_app_number] => 11/914098 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6498 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130129.pdf [firstpage_image] =>[orig_patent_app_number] => 11914098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834258 [patent_doc_number] => 20060246088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same' [patent_app_type] => utility [patent_app_number] => 11/407125 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5006 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246088.pdf [firstpage_image] =>[orig_patent_app_number] => 11407125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851743 [patent_doc_number] => 20060234934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Composition and Method for Selective Cytostasis' [patent_app_type] => utility [patent_app_number] => 11/279963 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10534 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234934.pdf [firstpage_image] =>[orig_patent_app_number] => 11279963 [rel_patent_id] =>[rel_patent_doc_number] =>)